Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.

× No keyword cloud information.

20 in total

1. In vitro effectiveness of four cephalosporins against Shigellae and clinical ineffectiveness of cephaloglycin.

Authors: J D Nelson; K C Haltalin
Journal: Chemotherapy Date: 1972 Impact factor: 2.544

2. Failure of furazolidone therapy in shigellosis.

Authors: K C Haltalin; J D Nelson
Journal: Am J Dis Child Date: 1972-01

3. Antibiotic resistance in Shigella mediated by R factors.

Authors: W E Farrar; M Eidson
Journal: J Infect Dis Date: 1971-05 Impact factor: 5.226

4. Comparison of intramuscular and oral ampicillin therapy for shigellosis.

Authors: K C Haltalin; J D Nelson; H T Kusmiesz; L V Hinton
Journal: J Pediatr Date: 1968-10 Impact factor: 4.406

5. Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin.

Authors: K C Haltalin; J D Nelson; L V Hinton; H T Kusmiesz; M Sladoje
Journal: J Pediatr Date: 1968-05 Impact factor: 4.406

6. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.

Authors: L A Fernandez
Journal: J Kans Med Soc Date: 1966-07

7. In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications.

Authors: J D Nelson; K C Haltalin
Journal: Ann N Y Acad Sci Date: 1966-06-14 Impact factor: 5.691

8. Antibiotic susceptibility testing by a standardized single disk method.

Authors: A W Bauer; W M Kirby; J C Sherris; M Turck
Journal: Am J Clin Pathol Date: 1966-04 Impact factor: 2.493

9. Antibiotic resistance of Shigella sonnei.

Authors: J R Davies; W N Farrant; A H Uttley
Journal: Lancet Date: 1970-12-05 Impact factor: 79.321

10. Microbioassay of antimicrobial agents.

Authors: H J Simon; E J Yin
Journal: Appl Microbiol Date: 1970-04

12 in total

Review 1. Antibiotic therapy for Shigella dysentery.

Authors: Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal: Cochrane Database Syst Rev Date: 2010-08-04

2. Comparative efficacy of cephalexin and ampicillin for shigellosis and other types of acute diarrhea in infants and children.

Authors: J D Nelson; K C Haltalin
Journal: Antimicrob Agents Chemother Date: 1975-04 Impact factor: 5.191

3. Enteropathogenic Esch. coli gastroenteritis in premature infants and children treated with fosfomycin.

Authors: F Baquero; E Canedo; A RODRIGUEZ; E Jaso
Journal: Arch Dis Child Date: 1975-05 Impact factor: 3.791

4. Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones.

Authors: J Ling; K M Kam; A W Lam; G L French
Journal: Antimicrob Agents Chemother Date: 1988-01 Impact factor: 5.191

5. Antimicrobial susceptibilities of shigellae isolated in Houston, Texas, in 1974.

Authors: P A Byers; H L Dupont; M C Goldschmidt
Journal: Antimicrob Agents Chemother Date: 1976-02 Impact factor: 5.191

6. Antimicrobial resistance of Shigella isolates causing traveler's diarrhea.

Authors: J Vila; J Gascon; S Abdalla; J Gomez; F Marco; A Moreno; M Corachan; T Jimenez de Anta
Journal: Antimicrob Agents Chemother Date: 1994-11 Impact factor: 5.191

7. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.

Authors: F Rogerie; D Ott; J Vandepitte; L Verbist; P Lemmens; I Habiyaremye
Journal: Antimicrob Agents Chemother Date: 1986-05 Impact factor: 5.191

Review 8. Use of quinolones in the treatment of gastrointestinal infections.

Authors: H L DuPont
Journal: Eur J Clin Microbiol Infect Dis Date: 1991-04 Impact factor: 3.267

Review 9. Quinolones and the gastrointestinal tract.

Authors: B E Murray
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-12 Impact factor: 3.267

10. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.

Authors: D L Shungu; E Weinberg; H H Gadebusch
Journal: Antimicrob Agents Chemother Date: 1983-01 Impact factor: 5.191